← Leaderboards
Norman H Bell
Medical University Of South Carolina
$1,281,695
Attributed
$1,281,695
Total exposure
12
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $225.2K · FY2005–07$250K$187.5K$125K$62.5K$0
'05
'06
'07
Funding mix
By agency
NIH$1,281,695 · 12
By mechanism
R01$1,238,769 · 2
M01$42,926 · 10
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- B Hildreth$0
- W A Brzezinski$0
- Lyndon L Key$25,066
- Jack F Otteni$0
- Sebastiano Gattoni-Celli$697,316
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchOsteoporosisHuman Therapy EvaluationDrug Screening /EvaluationDrug Adverse EffectSkeletal Disorder ChemotherapyWomen'S HealthFemalePostmenopauseBone DensityLongitudinal Human StudyAlendronatePlacebosOral AdministrationCytochrome P450Molecular CloningLaboratory RabbitDosageVitamin D DeficiencyMolecular PathologyAnimal Genetic Material TagHuman Genetic Material TagGenetic Mapping
Grant awards (20)
REGULATION OF VITAMIN D METABOLISM$9,605
M01 · FY2007 · RR · contact PI
CLONING AND CHARACTERIZATION OF HUMAN CYP25$211,680
R01 · FY2005 · DK
CLONING AND CHARACTERIZATION OF HUMAN CYP 25$13,476
M01 · FY2005 · RR
CLONING AND CHARACTERIZATION OF HUMAN CYP25$211,680
R01 · FY2004 · DK
Cloning and Characterization of Human CYP 25$19,845
M01 · FY2004 · RR
CLONING AND CHARACTERIZATION OF HUMAN CYP25$211,680
R01 · FY2003 · DK
CLONING AND CHARACTERIZATION OF HUMAN CYP25$211,680
R01 · FY2002 · DK
ALENDRONATE IN POSTMENOPAUSAL OSTEOPOROTIC BONE DENSITY$0
M01 · FY2002 · RR
CLONING AND CHARACTERIZATION OF HUMAN CYP25$211,680
R01 · FY2001 · DK
BIOCHEMISTRY AND GENETICS OF VITAMIN D RECEPTOR ACTIONS$180,369
R01 · FY2001 · DK
ALENDRONATE IN POSTMENOPAUSAL OSTEOPOROTIC BONE DENSITY$0
M01 · FY2001 · RR
ALENDRONATE IN POSTMENOPAUSAL OSTEOPOROTIC BONE DENSITY$0
M01 · FY2001 · RR
ALENDRONATE IN POSTMENOPAUSAL OSTEOPOROTIC BONE DENSITY$0
M01 · FY2001 · RR
ALENDRONATE IN POSTMENOPAUSAL OSTEOPOROTIC BONE DENSITY$0
M01 · FY2000 · RR
ALENDRONATE, MIACALCIN IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2000 · RR
ALENDRONATE TRIAL IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2000 · RR
RALOXIFENE HCL IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2000 · RR
ALENDRONATE IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2000 · RR
ALENDRONATE SODIUM FOR OSTEOPOROSIS IN MEN$0
M01 · FY2000 · RR
IBANDRONATE IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2000 · RR